Envoy Medical (NASDAQ:COCH) Trading Down 3.1% – Should You Sell?

Shares of Envoy Medical, Inc. (NASDAQ:COCH) were down 3.1% during trading on Thursday . The stock traded as low as $1.56 and last traded at $1.56. Approximately 9,962 shares traded hands during trading, a decline of 67% from the average daily volume of 29,811 shares. The stock had previously closed at $1.61.

Wall Street Analyst Weigh In

COCH has been the subject of several research reports. Brookline Capital Management initiated coverage on shares of Envoy Medical in a research report on Monday, October 14th. They set a “buy” rating and a $9.00 price objective for the company. Ascendiant Capital Markets lifted their price target on Envoy Medical from $8.75 to $9.00 and gave the stock a “buy” rating in a report on Friday, December 6th.

Envoy Medical Stock Down 1.3 %

The firm’s 50-day moving average price is $1.68 and its 200 day moving average price is $2.32.

Hedge Funds Weigh In On Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Lake Street Advisors Group LLC acquired a new stake in Envoy Medical, Inc. (NASDAQ:COCH) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 45,455 shares of the company’s stock, valued at approximately $65,000. Lake Street Advisors Group LLC owned 0.22% of Envoy Medical as of its most recent SEC filing. 8.59% of the stock is owned by institutional investors and hedge funds.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.